MedPath

To Study the Effect of Transcranial Magnetic Stimulation on Cerebellum vermis in treatment resistant schizophrenia as compare to placebo stimulatio

Phase 3
Conditions
Health Condition 1: F20- Schizophrenia
Registration Number
CTRI/2020/06/025811
Lead Sponsor
Shri Guru Ram rai institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)-Diagnosis of schizophrenia, according to International Classification of Diseases-10 Diagnostic Criteria for Research (ICD-10)(DCR).

2)-Treatment Resistant Schizophrenia pro-bands would be selected according to Modified Kane Criteria.

3)-Right handed, Normotensive patient.

Exclusion Criteria

1)-Neurological disorders with history of epilepsy, organic brain damage or any neurological procedures.

2)-Subjects with pacemakers or other metal parts in the body.

3)-Subjects who have received ECT in past 6 months.

4)-Any substance use disorders except nicotine and caffeine(ICD-10 DCR).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
positive and negative symptoms scaleTimepoint: rating would be done on 0, 7 and 21 days
Secondary Outcome Measures
NameTimeMethod
simpson-angus extrapyramidal side effects scale, schizophrenia cognition rating score, brief psychiatric rating scale, clinical global impressionTimepoint: rating would be done on 0, 7 and 21 days
© Copyright 2025. All Rights Reserved by MedPath